Literature DB >> 22710352

Klotho inhibits the capacity of cell migration and invasion in cervical cancer.

Boogi Chang1, Jinsun Kim, Dongjun Jeong, Yujun Jeong, Seob Jeon, Sam-Il Jung, Young Yang, Keun Il Kim, Jong-Seok Lim, Changjin Kim, Myeong-Sok Lee.   

Abstract

Aberrant activation of the Wnt/β-catenin signaling pathway is common in human cervical cancers. However, the mechanisms of Wnt activation in cervical cancer remain largely unknown. In the present study, we demonstrate that Klotho, a Wnt antagonist, is downregulated in invasive human cervical tumors and in a cell line we analyzed. Our data demonstrated that in vivo Klotho expression was not observed in invasive cervical carcinoma. In vitro restoration of Klotho expression in SiHa cells resulted in a decreased cell motility and invasiveness through upregulation of E-cadherin, downregulation of N-cadherin and reduced expression of MMP7 and -9. Ectopic expression of Klotho also reduced the expression of the epithelial-to-mesenchymal transition (EMT) transcription factors Slug and Twist. Furthermore, Klotho causes a significant inhibition of the Wnt/β-catenin pathway in cervical cancer cells, as supported by the expression of Wnt/β-catenin transcriptional target genes such as c-Myc and cyclin D1. Consequently, our findings demonstrate for the first time that Klotho regulates tumor invasion through the EMT process and provide novel mechanistic insights into the role of Klotho in cervical cancer progression and contribute to treatment for metastatic cervical cancer patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22710352     DOI: 10.3892/or.2012.1865

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  28 in total

1.  MicroRNA-339 and microRNA-556 regulate Klotho expression in vitro.

Authors:  Stephen J Mehi; Astha Maltare; Carmela R Abraham; Gwendalyn D King
Journal:  Age (Dordr)       Date:  2013-07-02

2.  The anti-aging and tumor suppressor protein Klotho enhances differentiation of a human oligodendrocytic hybrid cell line.

Authors:  Ci-Di Chen; Hu Li; Jennifer Liang; Kathryn Hixson; Ella Zeldich; Carmela R Abraham
Journal:  J Mol Neurosci       Date:  2014-06-08       Impact factor: 3.444

3.  Klotho expression is correlated to molecules associated with epithelial-mesenchymal transition in lung squamous cell carcinoma.

Authors:  Takayuki Ibi; Jitsuo Usuda; Tatsuya Inoue; Akira Sato; Kyoshiro Takegahara
Journal:  Oncol Lett       Date:  2017-08-31       Impact factor: 2.967

4.  Assessment of the circulating klotho protein in lung cancer patients.

Authors:  Judit Pako; Andras Bikov; Imre Barta; Hideyo Matsueda; Rita Puskas; Gabriella Galffy; Anna Kerpel-Fronius; Balazs Antus; Ildiko Horvath
Journal:  Pathol Oncol Res       Date:  2018-06-12       Impact factor: 3.201

5.  Klotho deficiency disrupts hematopoietic stem cell development and erythropoiesis.

Authors:  Sangeetha Vadakke Madathil; Lindsay M Coe; Carla Casu; Despina Sitara
Journal:  Am J Pathol       Date:  2014-01-08       Impact factor: 4.307

6.  Human alternative Klotho mRNA is a nonsense-mediated mRNA decay target inefficiently spliced in renal disease.

Authors:  Rik Mencke; Geert Harms; Jill Moser; Matijs van Meurs; Arjan Diepstra; Henri G Leuvenink; Jan-Luuk Hillebrands
Journal:  JCI Insight       Date:  2017-10-19

7.  Targeting the eIF4E/β-catenin axis sensitizes cervical carcinoma squamous cells to chemotherapy.

Authors:  Hai Xu; Zhiyin Wang; Lang Xu; Guoyan Mo; Gangfeng Duan; Yali Wang; Zhengang Sun; Hao Chen
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

Review 8.  Klotho: a novel biomarker for cancer.

Authors:  Xiangxiang Zhou; Xin Wang
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-03       Impact factor: 4.553

Review 9.  Role of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives.

Authors:  Xiao-Mei Zhou; Hai Zhang; Xia Han
Journal:  Tumour Biol       Date:  2014-08-29

10.  Lysyl Oxidase (LOX) Transcriptionally Regulates SNAI2 Expression and TIMP4 Secretion in Human Cancers.

Authors:  Myriem Boufraqech; Lisa Zhang; Naris Nilubol; Samira M Sadowski; Shweta Kotian; Martha Quezado; Electron Kebebew
Journal:  Clin Cancer Res       Date:  2016-03-30       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.